Clinical Cancer Advances 2008: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology
Eric P. Winer(University of Vermont), Richard L. Schilsky(American Society of Clinical Oncology), Gregory Reaman(American Society of Clinical Oncology), Lisa Diller(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Patrick J. Loehrer(Indiana Cancer Consortium), Julie R. Gralow(American Society of Clinical Oncology), George D. Demetri(American Society of Clinical Oncology), Lori J. Pierce(University of Michigan–Ann Arbor), Mark G. Kris(Memorial Sloan Kettering Cancer Center), Howard M. Sandler(Cedars-Sinai Medical Center), Robert J. Mayer(Applied Natural Sciences), Derek Raghavan(United States Department of Veterans Affairs), Linda T. Vahdat(Dartmouth–Hitchcock Medical Center), John Sweetenham(Cleveland Clinic), Beth Y. Karlan(University of California, Los Angeles), David Pfister(American Society of Clinical Oncology), Raymond Sawaya(American University of Beirut Medical Center), Patricia A. Ganz(Los Angeles County Department of Public Health), Barnett S. Kramer(University of Pittsburgh), Maurie Markman(The University of Texas MD Anderson Cancer Center), Scott Ramsey(American Society of Clinical Oncology), Lynn M. Schuchter(Eastern Cooperative Oncology Group)
Cited by 290
Related Papers
Current and future burden of breast cancer: Global statistics for 2020 and 2040
|The Breast|2022|3.3k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
|New England Journal of Medicine|2003|2.6k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k